| Classify | Properties | Product Name | Cat# | Price |
|
|---|
| Adjuvants for protein-based vaccines | Squalene Emulsion | SqualVax | ADJU-010CL-1 | INQUIRY |
|
| Aluminum Gels | Alhydrogel 2% | ADJU-011CL | INQUIRY |
|
| AlumVax Hydroxide | ADJU-011CL-1 | INQUIRY |
|
| AlumVax Phosphate | ADJU-011CL-2 | INQUIRY |
|
Freund's Adjuvant
Complete Freund's Adjuvant | CFA | ADJU-012CL | INQUIRY |
|
| CFAVax | ADJU-012CL-1 | INQUIRY |
|
Freund's Adjuvant
Incomplete Freund's adjuvant | IFA | ADJU-013CL | INQUIRY |
|
| IFAVax | ADJU-013CL-1 | INQUIRY |
|
NLRP3 inflammasome inducer - Deacetylated derivative of chitin
Th1/Th2 response | Chitosan | ADJU-046CL | INQUIRY |
|
| Aluminum Gels | 2% Aluminum hydroxide adjuvant (Vaccine adjuvant) | DADF-041 | INQUIRY |
|
| Aluminum Gels | 2% Aluminum phosphate adjuvant (Vaccine adjuvant) | DADF-042 | INQUIRY |
|
| Calcium phosphate | Calcium phosphate adjuvant (Vaccine adjuvant) | DADF-043 | INQUIRY |
|
| Freunds Adjuvant | Classical Adjuvant Combo Pak-1 (contains 10 ml each CFA (#DAGF-051), IFA (#DAGF-053), and Squalene (#DAGF-055) | DADF-050 | INQUIRY |
|
| Complete Freunds Adjuvant | Complete Freunds Adjuvant (CFA, Vaccine adjuvant) | DADF-051 | INQUIRY |
|
| Incomplete Freunds Adjuvant | Incomplete Freunds Adjuvant (IFA, Vaccine adjuvant) | DADF-053 | INQUIRY |
|
| Quillaja saponaria | Quillaja saponaria (>95%, EU GMP grade, Vaccine adjuvant) | DADF-054 | INQUIRY |
|
| Squalene | Squalene (oil-in-water nano emulsion, Vaccine adjuvant) | DADF-055 | INQUIRY |
|
| Vet-SAP | Vet-SAP (>95%, EU GMP grade, Vaccine adjuvant) | DADF-057 | INQUIRY |
|
| Peanut Oil | Peanut Oil (vaccine adjuvant) | DADF-060 | INQUIRY |
|
| Mineral Oil | Mineral Oil (vaccine adjuvant) | DADF-061 | INQUIRY |
|
| Mannide monooleate | Mannide monooleate (vaccine adjuvant) | DADF-062 | INQUIRY |
|
| HS15 Kolliphore | HS15 Kolliphore vaccine adjuvant | DADF-063 | INQUIRY |
|
| TLR5 agonist | Recombinant flagellin FlicC (TLR5 agonist, vaccine adjuvant) | DADF-065 | INQUIRY |
|
| MPLA | Monophosphoryl lipid A (MPLA) (Synthetic, TLR4/Th1, vaccine adjuvant) | DADF-069 | INQUIRY |
|
| Diphosphoryl Lipid A | Diphosphoryl Lipid A (E. coli K12 D31m4) | DADF-070 | INQUIRY |
|
| Tetani toxin Light-chain | Recombinant purified tetani toxin Light-chain (Non toxic) | DADF-074 | INQUIRY |
|
| Tetani toxin | Recombinant purified (P. fluorescens) low endotoxin tetani toxin C-terminal fragment (52 KDa, >95%) | DADF-077 | INQUIRY |
|
| Diphtheria Toxoid | Purified Diphtheria Toxoid protein (antigen grade) | DADF-080 | INQUIRY |
|
| Pam2CSK4 | Pam2CSK4 vaccine adjuvant, unlabeled | DADF-082 | INQUIRY |
|
| Diphtheria Toxoid | Purified Diphtheria Toxoid protein (antigen grade) | DADF-083 | INQUIRY |
|
| CRM197 | Purified CRM197 (Diphtheria Toxin mutant) protein (vaccine grade) | DADF-086 | INQUIRY |
|
| RWJ 21757 | RWJ 21757 Synthetic (vaccine adjuvant) | DADF-087 | INQUIRY |
|
| TDB | TDB (Trehalose-6,6-dibehenate) Synthetic (vaccine adjuvant) | DADF-088 | INQUIRY |
|
| Pam2CSK4 | Pam2CSK4 (vaccine adjuvant) [Biotin] | DADF-089 | INQUIRY |
|
| Cholera Toxin | Purified Cholera Toxin protein (vaccine grade) | DADF-092 | INQUIRY |
|
| PRR Ligands-based adjuvant | STING ligand - Cyclic [G(3',5')pA(3',5')p] | 3'3'-cGAMP | ADJU-014CL | INQUIRY |
|
| STING ligand - Cyclic [G(2',5')pA(3',5')p] | 2'3'-cGAMP | ADJU-015CL | INQUIRY |
|
| STING ligand - Cyclic [G(2',5')pA(2',5')p] | 2'2'-cGAMP | ADJU-016CL | INQUIRY |
|
STING ligand - CDS agonist - Cyclic diadenylate monophosphate
Th1 / Th2 response | c-di-AMP | ADJU-017CL | INQUIRY |
|
STING ligand - CDS agonist - Cyclic diguanylate monophosphate
Th1 / Th2 response | c-di-GMP | ADJU-018CL | INQUIRY |
|
NOD2 Agonist - N-glycolylated muramyldipeptide
Th1 response | N-Glycolyl-MDP | ADJU-019CL | INQUIRY |
|
Mincle agonist - Synthetic analog of the cord factor
Th1 response | TDB | ADJU-020CL | INQUIRY |
|
Mincle agonist - Synthetic analog of the cord factor formulated with HS15
Th1 response | TDB-HS15 | ADJU-021CL | INQUIRY |
|
TLR1/2 agonist - Synthetic triacylated lipoprotein
Th1 response | Pam3CSK4 | ADJU-022CL | INQUIRY |
|
TLR3 agonist - Polyinosine-polycytidylic acid
Th1 response | Poly(I:C) (HMW) | ADJU-023CL | INQUIRY |
|
| Lipopolysaccharide from E. coli 0111:B4 strain - TLR4-based adjuvant | LPS-EB | ADJU-024CL | INQUIRY |
|
TLR4 agonist - Monophosphoryl lipid A
Th1 response | MPLA-SM | ADJU-025CL | INQUIRY |
|
TLR4 agonist - Synthetic monophosphoryl lipid A
Th1 response | MPLA Synthetic | ADJU-026CL | INQUIRY |
|
TLR5 Agonist - Recombinant flagellin
Th1/Th2 response | Flagellin FliC | ADJU-027CL | INQUIRY |
|
TLR7 agonist - Imidazoquinoline compound
Th1 response | Gardiquimod | ADJU-028CL | INQUIRY |
|
TLR7 agonist - Imidazoquinoline compound
Th1 response | Imiquimod | ADJU-029CL | INQUIRY |
|
TLR7/8 agonist - Imidazoquinoline compound
Th1 response | R848 | ADJU-030CL | INQUIRY |
|
TLR9 agonist - CpG ODN, class A (murine)
Th1 response | ODN 1585 | ADJU-031CL | INQUIRY |
|
TLR9 agonist - CpG ODN, class A (human)
Th1 response | ODN 2216 | ADJU-047CL | INQUIRY |
|
TLR9 agonist - CpG ODN, class A (human)
Th1 response | ODN 2336 | ADJU-048CL | INQUIRY |
|
TLR9 agonist - CpG ODN, class B (murine)
Th1 response | ODN 1826 | ADJU-032CL | INQUIRY |
|
TLR9 agonist - CpG ODN, class B (murine)
Th1 response | ODN 1668 | ADJU-049CL | INQUIRY |
|
TLR9 agonist - CpG ODN, class B (bovine/porcine)
Th1 response | ODN 2007 | ADJU-050CL | INQUIRY |
|
TLR9 agonist - CpG ODN, class B (multispecies)
Th1 response | ODN D-SL01 | ADJU-051CL | INQUIRY |
|
TLR9 agonist - CpG ODN, class B (human)
Th1 response | ODN BW006 | ADJU-052CL | INQUIRY |
|
TLR9 agonist - CpG ODN, class B (human)
Th1 response | ODN 2006 | ADJU-033CL | INQUIRY |
|
TLR9 agonist - CpG ODN, class C (human/mouse)
Th1 response | ODN 2395 | ADJU-034CL | INQUIRY |
|
TLR9 agonist - CpG ODN, class C (human/mouse)
Th1 response | ODN M362 | ADJU-053CL | INQUIRY |
|
TLR9 agonist - CpG ODN, class C (multispecies)
Th1 response | ODN D-SL03 | ADJU-054CL | INQUIRY |
|
| LPS | Lipopolysaccharides (LPS) (Escherichia coli 0111:B4, vaccine adjuvant) | DADF-066 | INQUIRY |
|
| LPS | Ultrapure Lipopolysaccharides (LPS) (Escherichia coli 0111:B4, TLR4 tested, vaccine adjuvant) | DADF-067 | INQUIRY | |
| LPS | Lipopolysaccharides (LPS) (Salmonella typhimurium, vaccine adjuvant) | DADF-068 | INQUIRY | |
| Others | Peptidoglycan | Peptidoglycan (S. aureus, vaccine adjuvant) | DADF-071 | INQUIRY | |
| MPLA | Monophosphoryl lipid A (MPLA)-SM (S. enterica Minnesota, R595, vaccine adjuvant) | DADF-072 | INQUIRY | |
| TLR7 agonist | Gardiquimod (TLR7 agonist/Imidazoquinoline), antigen grade | DADF-075 | INQUIRY | |
| MDP | MDP, muramyldipetide (Ac-muramyl-Ala-D-Glu-amide) Synthetic (vaccine adjuvant) | DADF-076 | INQUIRY | |
| TLR7 agonist | Imiquimod (TLR7 agonist/Imidazoquinoline), antigen grade | DADF-078 | INQUIRY | |
| TLR7/8 agonist | Resiquimod (Imidazoquinoline compound)-TLR7/8 agonist, antigen grade | DADF-079 | INQUIRY | |
